Intervertebral Disc Degeneration and Associated Pain Mechanisms

Intervertebral disc degeneration represents a multifactorial process in which alterations in cell viability, extracellular matrix composition and mechanical loading converge to undermine spinal integrity and precipitate pain. The disc is composed of a hydrophilic nucleus pulposus encased by the circumferential lamellae of the annulus fibrosus and capped by cartilaginous endplates. Age‐related changes, mechanical overload and biochemical insults provoke a shift towards catabolic enzyme expression, resulting in proteoglycan loss, fibrillation of collagen and reduced hydration. Concurrently, cellular senescence and apoptosis diminish reparative capacity. Loss of disc height and fissuring of the annulus permit nociceptive nerve and vascular ingrowth, sensitised by local production of proinflammatory cytokines and neurotrophic factors. These mediators amplify pain signalling through spinal and peripheral pathways, underpinning the clinical manifestations of low back pain. Global ageing, sedentary lifestyles and metabolic disorders exacerbate the burden of disc degeneration, driving a need for therapies that not only alleviate symptoms but also restore disc homeostasis and inhibit aberrant pain signalling.

Research from Nature Portfolio

Recent studies have harnessed microRNA modulation to intervene in disc remodelling. Preclinical work on miR-141 demonstrates that precise downregulation of this small RNA attenuates nucleus pulposus cell apoptosis and matrix breakdown. By targeting the SIRT1–NF-κB axis, nanoparticle‐mediated delivery of miR-141 inhibitors restores anabolic–catabolic balance in experimental models, yielding structural and functional improvements. These findings highlight the promise of gene‐based strategies for halting degenerative cascades and mitigating discogenic pain at a molecular level.

Intervertebral Disc Degeneration and Associated Pain Mechanisms publication trend

The graph below shows the total number of articles in intervertebral disc degeneration and associated pain mechanisms across all publications each year (not limited to Nature Index journals).

Technical terms

Nucleus pulposus: Inner gel-like core of the intervertebral disc responsible for distributing compressive loads.

Annulus fibrosus: Outer fibrocartilaginous ring of the disc providing tensile strength and containment of the nucleus pulposus.

MicroRNA (miRNA): Small non-coding RNA molecules that regulate gene expression by inhibiting target genes post-transcriptionally.

Extracellular matrix: Network of collagen, proteoglycans and glycoproteins that maintains disc hydration and mechanical resilience.

Catabolism: Metabolic breakdown of complex molecules, here referring to matrix degradation by enzymes such as matrix metalloproteinases.

Inflammatory mediators: Bioactive molecules, including cytokines and chemokines, that promote inflammation and sensitise pain pathways in disc tissue.

References

1. D-mannose alleviates intervertebral disc degeneration through glutamine metabolism. Military Medical Research (2024).
2. Preclinical development of a microRNA-based therapy for intervertebral disc degeneration. Nature Communications (2018).
3. Accelerated cellular senescence in degenerate intervertebral discs: a possible role in the pathogenesis of intervertebral disc degeneration. Arthritis Research & Therapy (2007).
4. Painful intervertebral disc degeneration and inflammation: from laboratory evidence to clinical interventions. Bone Research (2021).